Rami Jabbour
Hospitalist · Hattiesburg, MSNPI 1679980072
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.5% of the total across 88 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $684 and has fallen 78.9% since, to $145 in 2025.
Across 88 payments — averaging $21.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$388
- Boehringer Ingelheim$343
- Johnson & Johnson$327
- AstraZeneca$224
- E.r. Squibb & Sons, L.L.C.$166
- Novartis$120
- plus $321 from 7 others
What the payments were for
- Food & beverage$1,80495%
- Education$855%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 18 | $388 |
| Boehringer Ingelheim | 15 | $343 |
| Johnson & Johnson | 15 | $327 |
| AstraZeneca | 7 | $224 |
| E.r. Squibb & Sons, L.L.C. | 12 | $166 |
| Novartis | 6 | $120 |
| Pfizer | 6 | $95 |
| Amgen | 1 | $68 |
| Viatris Specialty LLC | 3 | $65 |
| Gilead | 2 | $31 |
| Portola Pharmaceuticals, LLC | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $22 |
| Inari Medical, Inc. | 1 | $16 |
How this compares
$1,889 in reported general payments places this provider in the 85th percentile of 102 hospitalist providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 37 | $348 |
| Levetiracetam | 20 | $204 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 34 | $193 |
| CefuroximeCefuroxime Axetil | 15 | $162 |
| Rosuvastatin Calcium | 16 | $141 |
| Metoprolol Succinate | 18 | $112 |
| Atorvastatin Calcium | 19 | $88 |
| Prednisone | 34 | $87 |
| ClopidogrelClopidogrel Bisulfate | 17 | $74 |
| Amlodipine Besylate | 29 | $69 |
| Doxycycline Monohydrate | 11 | $66 |
| Levofloxacin | 21 | $64 |
| Furosemide | 20 | $60 |
| Metoprolol Tartrate | 16 | $56 |
| Hydralazine Hcl | 11 | $53 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Hattiesburg
- Cherie PapizanHattiesburg$2K
- Volkan OzduranHattiesburg$2K
- Sriharsha AthotaHattiesburg$2K
- Roland EstarisHattiesburg$1K
- Subodh AdhikariHattiesburg$1K
- Mohammad AnindoHattiesburg$1K
- Paul DrambareanHattiesburg$1K
- Abdul MinhasHattiesburg$1K
- Gregg AnaziaHattiesburg$1K
- Keerthi BandaHattiesburg$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.